Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A botulinum neurotoxin-like function of Potentilla chinensis extract that inhibits neuronal SNARE complex formation, membrane fusion, neuroexocytosis, and muscle contraction.

Jung CH, Choi JK, Yang Y, Koh HJ, Heo P, Yoon KJ, Kim S, Park WS, Shing HJ, Kweon DH.

Pharm Biol. 2012 Sep;50(9):1157-67. doi: 10.3109/13880209.2012.661743.

PMID:
22881141
2.

Inhibition of SNARE-driven neuroexocytosis by plant extracts.

Jung CH, Yang YS, Kim JS, Shin YK, Hwang JS, Son ED, Lee HH, Chung KM, Oh JM, Lee JH, Kweon DH.

Biotechnol Lett. 2009 Mar;31(3):361-9. doi: 10.1007/s10529-008-9878-z. Epub 2008 Nov 20.

PMID:
19023663
3.

A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion.

Jung CH, Yang YS, Kim JS, Shin JI, Jin YS, Shin JY, Lee JH, Chung KM, Hwang JS, Oh JM, Shin YK, Kweon DH.

FEBS J. 2008 Jun;275(12):3051-63. doi: 10.1111/j.1742-4658.2008.06458.x. Epub 2008 May 6.

4.

SNARE-wedging polyphenols as small molecular botox.

Yang Y, Choi JK, Jung CH, Koh HJ, Heo P, Shin JY, Kim S, Park WS, Shin HJ, Kweon DH.

Planta Med. 2012 Feb;78(3):233-6. doi: 10.1055/s-0031-1280385. Epub 2011 Nov 22.

PMID:
22109835
5.

[Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].

Doussau F, Humeau Y, Vitiello F, Popoff MR, Poulain B.

J Soc Biol. 1999;193(6):457-67. Review. French.

PMID:
10783704
6.

SNARE zippering is hindered by polyphenols in the neuron.

Yang Y, Kim SH, Heo P, Kong B, Shin J, Jung YH, Yoon K, Chung WJ, Shin YK, Kweon DH.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):831-6. doi: 10.1016/j.bbrc.2014.06.064. Epub 2014 Jun 21.

7.

SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis.

Banerjee A, Kowalchyk JA, DasGupta BR, Martin TF.

J Biol Chem. 1996 Aug 23;271(34):20227-30.

8.

Rapid and selective binding to the synaptic SNARE complex suggests a modulatory role of complexins in neuroexocytosis.

Pabst S, Margittai M, Vainius D, Langen R, Jahn R, Fasshauer D.

J Biol Chem. 2002 Mar 8;277(10):7838-48. Epub 2001 Dec 20.

9.
10.

Engineered botulinum neurotoxins as new therapeutics.

Masuyer G, Chaddock JA, Foster KA, Acharya KR.

Annu Rev Pharmacol Toxicol. 2014;54:27-51. doi: 10.1146/annurev-pharmtox-011613-135935. Epub 2013 Aug 30. Review.

PMID:
24016211
11.

[Mechanisms of action of botulinum toxins and neurotoxins].

Poulain B, Lonchamp E, Jover E, Popoff MR, Molgó J.

Ann Dermatol Venereol. 2009 May;136 Suppl 4:S73-6. doi: 10.1016/S0151-9638(09)74531-4. Review. French.

PMID:
19576489
12.

Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.

Wang J, Zurawski TH, Bodeker MO, Meng J, Boddul S, Aoki KR, Dolly JO.

Biochem J. 2012 May 15;444(1):59-67. doi: 10.1042/BJ20120100.

PMID:
22360156
13.

Modulation of L-type Ca(2+) channels by distinct domains within SNAP-25.

Ji J, Yang SN, Huang X, Li X, Sheu L, Diamant N, Berggren PO, Gaisano HY.

Diabetes. 2002 May;51(5):1425-36.

14.

Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.

Gerachshenko T, Blackmer T, Yoon EJ, Bartleson C, Hamm HE, Alford S.

Nat Neurosci. 2005 May;8(5):597-605. Epub 2005 Apr 17.

PMID:
15834421
15.

Is the light chain subcellular localization an important factor in botulinum toxin duration of action?

Fernández-Salas E, Ho H, Garay P, Steward LE, Aoki KR.

Mov Disord. 2004 Mar;19 Suppl 8:S23-34.

PMID:
15027051
16.

Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.

Dolly JO, Wang J, Zurawski TH, Meng J.

FEBS J. 2011 Dec;278(23):4454-66. doi: 10.1111/j.1742-4658.2011.08205.x. Epub 2011 Jul 5.

17.

Abrogating Munc18-1-SNARE complex interaction has limited impact on exocytosis in PC12 cells.

Malintan NT, Nguyen TH, Han L, Latham CF, Osborne SL, Wen PJ, Lim SJ, Sugita S, Collins BM, Meunier FA.

J Biol Chem. 2009 Aug 7;284(32):21637-46. doi: 10.1074/jbc.M109.013508. Epub 2009 May 29.

18.

A signaling mechanism coupling netrin-1/deleted in colorectal cancer chemoattraction to SNARE-mediated exocytosis in axonal growth cones.

Cotrufo T, Pérez-Brangulí F, Muhaisen A, Ros O, Andrés R, Baeriswyl T, Fuschini G, Tarrago T, Pascual M, Ureña J, Blasi J, Giralt E, Stoeckli ET, Soriano E.

J Neurosci. 2011 Oct 12;31(41):14463-80. doi: 10.1523/JNEUROSCI.3018-11.2011.

19.

Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.

Raciborska DA, Trimble WS, Charlton MP.

Eur J Neurosci. 1998 Aug;10(8):2617-28.

PMID:
9767392
20.

The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Pantano S, Montecucco C.

Cell Mol Life Sci. 2014 Mar;71(5):793-811. doi: 10.1007/s00018-013-1380-7. Epub 2013 Jun 11. Review.

PMID:
23749048

Supplemental Content

Support Center